Cosmetics Label and Claim Audit Checklist
Guiding cosmetics firms in checking package labels, INCI naming, formulation thresholds, and avoiding illegal therapeutic claims.
Cosmetic labels are primary targets for border seizures and consumer lawsuits. Compliance keys include: all ingredients mapped to INCI naming; concentration limits obeyed; and absolute avoidance of "treatment, cure, or prevention of disease" drug claims. All efficacy claims must be supported by clinical testing or scientific literature dossiers.
1. Applicability & Scope
Applies to packaging boxes, bottle labels, inserts, brand online listings, and advertising details for all cosmetics sold in the EU and U.S. retail markets. It does not apply to non-cosmetic labels (such as prescription drugs, medical antiseptics, or household cleaners).
2. Regulatory Basis & Standards
Based on the U.S. Fair Packaging and Labeling Act (FPLA), Federal Food, Drug, and Cosmetic Act (FD&C Act) misbranding clauses, and EU Regulation (EU) No 655/2013 establishing common criteria for cosmetic claims, along with Article 19 of Regulation (EC) No 1223/2009.
3. Common Industry Misconceptions
Common myths: First, using drug claims carelessly. Printing claims like "reduces inflammation, treats eczema, or cures acne" on a cosmetic label without a drug registration will cause the FDA to classify it as an "unapproved new drug". Second, using "chemical-free" or "100% safe" claims; these are scientifically inaccurate and classified as misleading by regulators.
4. Required Documents Checklist
Before label and claim pre-audits, brands must supply the following materials:
- Bilingual quantitative formulation sheet and fragrance safety sheets (IFRA Certificates)
- Flat packaging layouts (high-res PDFs showing principal display and ingredient panels)
- Third-party clinical testing or consumer study reports validating specific efficacy claims
- Certificate of Free Sale or equivalent compliance declarations
5. How QTC Can Support
QTC checks formulation INCI naming accuracy, flags high-risk therapeutic claims, and recommends compliant wording. When patch tests, SPF tests, or similar data are needed, QTC coordinates CNAS/CMA-accredited testing resources and reviews report completeness.
6. Project Timeline & Process
Process: 1. Collect product formulations and label drafts; 2. Cross-check each ingredient against standard INCI indexes and concentration limits; 3. Screen marketing texts for sensitive therapeutic terms; 4. Match efficacy proof files with labeling claims; 5. Issue audit reports and revised label copy layouts.
7. Official Sources & Last Modified
Sources: U.S. FDA Cosmetics Labeling Guide and EU Regulation (EU) No 655/2013 on cosmetic claims. Content updated as of 2026.
8. Professional Review Team Profile
Reviewed by the QTC Consumer Products Compliance Department, consisting of senior regulatory consultants and former cosmetic R&D directors specialized in INCI catalog mapping and advertising law constraints.
FAQ
How do you prove moisturizing or anti-wrinkle claims? Can QTC sign off?+
QTC analyzes the Efficacy Claim Dossier to verify that existing studies match labeling claims. For consumer patch tests, 3D skin models, or similar data needs, QTC coordinates certified testing resources and reviews analytical outputs for dossier consistency.
Next steps
If this topic applies to your product, facility, or supply chain requirement, start by confirming the target market, customer-required standard, existing documents, audit history, and expected timeline.
